Acknowledgements
82002408
The phase 1b clinical trial was sponsored by Shanghai JMT-Bio Technology Co., Ltd., a subsidiary of CSPC Pharmaceutical Group Co., Ltd. (CSPC). The sponsor provided the investigated drugs and worked with investigators on the trial design, data collection, data analyses, and results interpretation. Genomic sequencing was provided by HaploX Biotechnology Co., Ltd. We thank Bo Peng from HaploX for conducting the bioinformatic analysis. We thank Tingyuan Yang for providing assistance in manuscript writing and editing. The study was also supported, in part, by the National Natural Science Foundation of China (82241232 awarded to L.Z., 82002408 awarded to S.Z., 82173101 awarded to W.F.). We thank patients and their families for participating in the clinical trial. We also thank investigators and clinical research coordinators from all study sites.